Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Legembre

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Cell and Developmental Biology|May 21, 2020
CD95 Structure, Aggregation and Cell SignalingNicolas Levoin, Mickael Jean, Patrick Legembre
Cell Death and Differentiation|April 15, 2025
CD95/Fas stoichiometry in future precision medicineMauricio Sica, Murielle Roussel, Patrick Legembre
Methods in Cell Biology|April 11, 2026
Protein-fragment complementation assays to analyze the CD95 complexDhouha Msalbi, Eden Lebrault, Patrick Legembre
Biochimica Et Biophysica Acta|May 1, 2014
The CD95/CD95L signaling pathway: a role in carcinogenesisAmélie Fouqué, Laure Debure, Patrick Legembre
Oncoscience|December 19, 2015
Chemotherapy with ceramide in TNBCPatrick Legembre, Olivier Micheau, Bruno Ségui
Cell Cycle (Georgetown, Tex.)|October 7, 2004
The relevance of NF-kappaB for CD95 signaling in tumor cellsPatrick Legembre, Bryan C Barnhart, Marcus E Peter
Archivum Immunologiae Et Therapiae Experimentalis|February 6, 2008
Rewinding the DISCBenjamin Chaigne-Delalande, Jean-François Moreau, Patrick Legembre
Biochimica Et Biophysica Acta|May 24, 2005
Does CD95 have tumor promoting activities?Marcus E Peter, Patrick Legembre, Bryan C Barnhart
Biochimica Et Biophysica Acta. Reviews on Cancer|October 21, 2023
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathwaysLayla Haymour, Mickael Jean, Cristian Smulski, et al.
Autophagy|February 18, 2009
An atypical necrotic signal induced by immunosuppressive and anti-viral agentsBenjamin Chaigne-Delalande, Gwendalline Guidicelli, Lionel Couzi, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Cell and Developmental Biology|May 21, 2020
CD95 Structure, Aggregation and Cell SignalingNicolas Levoin, Mickael Jean, Patrick Legembre
Cell Death and Differentiation|April 15, 2025
CD95/Fas stoichiometry in future precision medicineMauricio Sica, Murielle Roussel, Patrick Legembre
Methods in Cell Biology|April 11, 2026
Protein-fragment complementation assays to analyze the CD95 complexDhouha Msalbi, Eden Lebrault, Patrick Legembre
Biochimica Et Biophysica Acta|May 1, 2014
The CD95/CD95L signaling pathway: a role in carcinogenesisAmélie Fouqué, Laure Debure, Patrick Legembre
Oncoscience|December 19, 2015
Chemotherapy with ceramide in TNBCPatrick Legembre, Olivier Micheau, Bruno Ségui
Cell Cycle (Georgetown, Tex.)|October 7, 2004
The relevance of NF-kappaB for CD95 signaling in tumor cellsPatrick Legembre, Bryan C Barnhart, Marcus E Peter
Archivum Immunologiae Et Therapiae Experimentalis|February 6, 2008
Rewinding the DISCBenjamin Chaigne-Delalande, Jean-François Moreau, Patrick Legembre
Biochimica Et Biophysica Acta|May 24, 2005
Does CD95 have tumor promoting activities?Marcus E Peter, Patrick Legembre, Bryan C Barnhart
Biochimica Et Biophysica Acta. Reviews on Cancer|October 21, 2023
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathwaysLayla Haymour, Mickael Jean, Cristian Smulski, et al.
Autophagy|February 18, 2009
An atypical necrotic signal induced by immunosuppressive and anti-viral agentsBenjamin Chaigne-Delalande, Gwendalline Guidicelli, Lionel Couzi, et al.
Pageof 9